At 16.4% CAGR, North America Electronic Patient-Reported Outcomes (ePROS) Market is Projected to be Worth US$ 1,218.90 Million by 2031, says Business Market Insights

According to Business Market Insights' research, the North America electronic patient-reported outcomes (ePROS) market was valued at US$ 361.98 million in 2023 and is expected to reach US$ 1,218.90 million by 2031, registering a CAGR of 16.4% from 2023 to 2031. Integration of artificial intelligence and machine learning with ePROS platforms and increasing focus on patient-centered care are among the critical factors attributed to drive the North America electronic patient-reported outcomes (ePROS) market growth.

EPRO platforms integrate artificial intelligence (AI) and machine learning (ML) to improve data analysis and predictive analytics. Using these technologies, patterns in patient-reported data can be found, allowing for more individualized treatment plans and early detection of possible health problems. Deeper insights are also obtained by analyzing patient free-text responses using AI-driven natural language processing (NLP). For example, Medable, the digital health platform, and Clario integrate AI with their ePRO solutions to improve patient involvement, data accuracy, and real-time insights in clinical trials. These technological advancements are transforming ePRO systems, making them more efficient, accessible, and a major part of the digital health ecosystem. In August 2023, the next-generation, cutting-edge software platform from assisTek, a Pennsylvania-based Clinical Technology company, was intended to streamline their current eCOA (electronic Clinical Outcome Assessments) and ePRO (electronic Patient-Reported Outcomes) solutions. This state-of-the-art platform incorporates new features and upgrades, such as a proprietary custom operating system, AI-powered configurator, remote device provisioning for improved reusability, and single sign-on (SSO). Thus, the integration of artificial intelligence and machine learning with ePROS platforms, which offers new capabilities to enhance patient data collection, analysis, and integration, is expected to bring new trends in the electronic patient-reported outcomes (ePROS) market in the coming years.

On the contrary, data privacy and security issues hamper the growth of North America electronic patient-reported outcomes (ePROS) market.

By delivery mode, the North America electronic patient-reported outcomes (ePROS) market is segmented into cloud based and on-premises. The cloud based segment held 52.5% share of North America electronic patient-reported outcomes (ePROS) market share in 2023, amassing US$ 189.93 million. It is projected to garner US$ 617.59 million by 2031 to register 15.9% CAGR during 2023-2031.

In terms of application, the North America electronic patient-reported outcomes (ePROS) market is segmented into oncology, respiratory, and others. The oncology segment held 70.6% share of North America electronic patient-reported outcomes (ePROS) market share in 2023, amassing US$ 255.52 million. It is projected to garner US$ 884.68 million by 2031 to register 16.8% CAGR during 2023-2031.

By end user, the North America electronic patient-reported outcomes (ePROS) market is segmented into contract research organizations (CROs), pharmaceutical companies, and others. The pharmaceutical companies segment held 53.9% share of North America electronic patient-reported outcomes (ePROS) market share in 2023, amassing US$ 195.04 million. It is projected to garner US$ 651.91 million by 2031 to register 16.3% CAGR during 2023-2031.

Based on country, the North America electronic patient-reported outcomes (ePROS) market is categorized into the US, Canada, and Mexico. Our regional analysis states that the US captured 85.1% share of North America electronic patient-reported outcomes (ePROS) market in 2023. It was assessed at US$ 308.04 million in 2023 and is likely to hit US$ 1,048.01 million by 2031, registering a CAGR of 16.5% during 2023-2031.

Key players operating in the North America electronic patient-reported outcomes (ePROS) market are Assistek, Buddy Healthcare Ltd Oy, Castor, Clinical Ink Inc, Crucial Data Solutions, Curebase, Medable Inc, Medidata Solutions, Medrio, OpenClinica LLC, PatientIQ, Signant Health, Veeva Systems Inc, and Y-Prime LLC, among others.

•  August 2024, Clinical Ink launched EDCXtra, an innovative Electronic Data Capture (EDC) system. EDCXtra incorporates all existing DDC functionality into a single web-based application which includes Clinical ink's industry leading electronic Clinical Outcome Assessments (eCOAs) and eConsent solutions, providing a comprehensive, all-in-one GCP compliant platform.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com